HUTCHMED (China) Limited (HKG:0013)
23.26
+0.08 (0.35%)
At close: Feb 13, 2026
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 19.69 billion as of February 13, 2026. Its market cap has increased by 9.95% in one year.
Market Cap
19.69B
Enterprise Value
9.95B
Revenue
4.73B
Ranking
n/a
PE Ratio
5.37
Stock Price
23.26
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 1.87B to 19.69B, an increase of 955.19%. That is a compound annual growth rate of 12.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 19.69B | 5.13% |
| Dec 31, 2025 | 18.73B | -4.11% |
| Dec 31, 2024 | 19.53B | -18.73% |
| Dec 29, 2023 | 24.03B | 14.66% |
| Dec 30, 2022 | 20.96B | -56.27% |
| Dec 31, 2021 | 47.93B | 35.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 33.32B |
| Xuanzhu Biopharmaceutical | 32.73B |
| China Resources Pharmaceutical Group | 28.96B |
| Grand Pharmaceutical Group | 26.47B |
| Sunshine Lake Pharma | 24.99B |
| The United Laboratories International Holdings | 24.60B |
| Ab&B Bio-Tech CO., LTD. JS | 20.26B |
| Consun Pharmaceutical Group | 15.22B |